On March 2, 2021 CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, reported that its Chief Executive Officer, Steven Engle, will participate in a fireside chat with ROTH Senior Research Analyst Elemer Piros, Ph.D. at the 33rd Annual ROTH Conference, being held virtually March 15 – 17, 2021 (Press release, CohBar, MAR 2, 2021, View Source [SID1234575956]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

33rd Annual ROTH Conference
Tuesday, March 16, 2021 at 2:00 PM ET
Webcast: The presentation may be accessed via webcast at the scheduled time, or
following the presentation, using the following link:
View Source